Peter Kolchinsky

Apr 26, 2024 | shepherd.com | John LaMattina |Albert Bourla |Peter Kolchinsky |William Smith

The COVID-19 pandemic has been burned into the memory of the world. While millions died as a result of this virus, many more would have died if not for the discovery, development, and deployment of the mRNA vaccines. Pfizer CEO Albert Bourla takes you behind the scenes of the race to find this breakthrough vaccine, detailing the risks undertaken, the challenges that were faced, and the crises that were ultimately overcome to save the world.

Apr 23, 2024 | rapport.bio | Peter Kolchinsky

© Copyright 2001-2023 RA Capital Management, L.P. This website is for informational purposes only and does not constitute an offer to provide investment advisory or other services by RA Capital Management, L.P. (“RA Capital”). Nothing contained on the website constitutes investment advice, and the views expressed should not be taken as advice to buy, sell, or hold any security or as an endorsement of any security or company.

Apr 15, 2024 | rapport.bio | Peter Kolchinsky |Sarah Reed

April 15, 2024Companies are free to confidentially share data or other non-public information with investors of their choosing and complete a financing (such as a private investment in public equity, aka a PIPE) with those investors before publicly disclosing the data or other information, even the fact that the company is raising money in the first place. How is this fair?

Jan 4, 2024 | rapport.bio | Peter Kolchinsky |Tess Cameron

January 4, 2024With an insane amount of data analysis and insights by Alex Martinez-Forte, Jacqueline Rhuda, and Kris Shuman, and a massive graphics effort by Erin Clutter. * * *A year ago we published the first “Semper Maior” piece, making the case that biotech was on firm ground and ready for a reboot. We put out the second piece last summer, when it felt like the rebound was underway. Had the year ended in October or even November… well, you know.

Mar 12, 2023 | rapport.bio | Peter Kolchinsky |Josh Resnick |Tess Cameron |Kyle Teamey

By Kyle Teamey, Josh Resnick, Tess Cameron, and Peter KolchinskyKyle Teamey is Managing Partner, Planetary Health, at RA Capital Management. Josh Resnick is Managing Director at RA Capital Management. Tess Cameron is Principal, Strategic Finance, at RA Capital Management. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal.